A ResMed AirSense sleep apnea monitor. Courtesy ResMed

San Diego-based ResMed Inc., a maker of devices for treating sleep apnea, on Thursday reported 3 percent higher earnings on a 6 percent increase in sales.

The company reported earnings of $83 million, or 58 cents per share, on revenue of $380 million in the quarter ended Sept. 30. In the same period last year, the company earned $81 million, or 56 cents per share, on sales of $358 million.

“We had a successful start to fiscal year 2015, as new product launches drove revenue growth,” said Mick Farrell, ResMed’s chief executive officer. “Our results showed very strong performance from our European and Asia Pacific regions, as well as solid growth in the Americas.

“We are delivering on our promise to drive top-line revenue growth this fiscal year by launching a strong portfolio of new products, services, and solutions,” he said.

ResMed makes equipment for treating, diagnosing and managing sleep-disordered breathing, chronic obstructive pulmonary disease, and other chronic medical problems.

Show comments

Chris Jennewein

Chris Jennewein is Editor & Publisher of Times of San Diego.